N

NewAmsterdam Pharma

Biopharma developing LDL-C lowering CETP therapies

Vice President Corporate Communications - Corporate Communications

PR & CommunicationsConfirmed live in the last 24 hours
Full-timePennsylvania, USA

About the Job

Requirements

  • 15+ years of progressive communications leadership experience within biotechnology, pharmaceutical, or life sciences organizations, including significant experience leading corporate communications and product or pipeline communications functions.
  • Demonstrated success developing and executing communications strategies that support corporate reputation, pipeline advancement, regulatory milestones, commercial readiness, and business objectives.
  • Experience serving as a trusted advisor to CEOs, executive teams, and senior leaders in high-growth or high-stakes biotechnology environments.
  • Experience working in a publicly traded or investor-facing life sciences company.
  • Deep understanding of the biotechnology industry, drug development process, regulatory environment, healthcare stakeholder landscape, and communications considerations associated with potential product approval and launch.
  • Demonstrated success operating in a senior individual contributor capacity, balancing strategic leadership with hands-on execution while partnering effectively with agencies and cross-functional teams.
  • Proven experience managing high-profile communications initiatives, issues-management situations, crisis preparedness, and corporate reputation challenges.
  • Strong media relations experience with established relationships across healthcare, biotechnology, business, and financial media.
  • Exceptional written, verbal, and presentation skills, with the ability to translate complex scientific, regulatory, commercial, and business information into clear and compelling narratives.
  • Strong executive presence, sound business judgment, strategic thinking, and the ability to influence senior leadership and cross-functional teams.
  • Ability to thrive in a fast-paced, high-growth, matrixed biotechnology environment while balancing strategic leadership with operational excellence and hands-on execution.
  • Availability to attend in person at the Philadelphia-area office based on business needs and work requirements.
  • Willingness to travel based on business needs, including attendance at internal meetings and key company or industry events.

Responsibilities

  • Develop and lead an integrated communications strategy encompassing corporate communications, product and pipeline communications, executive communications, internal communications, digital communications, media relations, and reputation management.
  • Partner with the senior leadership team to define, strengthen, and consistently articulate the company’s corporate narrative across external and internal stakeholder audiences.
  • Serve as a trusted strategic communications advisor to the Chief Executive Officer, Chief Commercial Officer, Chief Financial Officer, Chief People Officer, executive leaders, and other senior leaders on positioning, messaging, thought leadership, media engagement, employee communications, and reputation management.
  • Lead communications planning and execution for major corporate milestones, including clinical data presentations, regulatory events, potential approval and launch-readiness milestones, scientific congresses, financing activities, business development activities, and other significant corporate announcements.
  • Develop and execute product and pipeline communications strategies that support late-stage development, regulatory readiness, and future commercial objectives.
  • Build and protect the company’s reputation through proactive issues preparedness, crisis communications planning, and rapid-response communications.
  • Oversee media relations strategy, cultivate relationships with healthcare, biotechnology, business, and financial media, and position the company as a credible voice within cardiovascular and other therapeutic-area communities.
  • Lead executive communications programs, including keynote presentations, external speaking engagements, thought leadership initiatives, internal leadership messaging, and strategic presentations.
  • Partner with the Chief People Officer to lead internal communications strategies that strengthen employee engagement, reinforce culture, and align employees around corporate priorities, business growth, and commercialization milestones.
  • Oversee the company’s digital communications ecosystem, including the corporate website, social media channels, and emerging communications platforms.
  • Establish communications objectives, metrics, and analytics to assess impact, monitor stakeholder engagement, and continuously improve performance.
  • Lead and provide strategic oversight to external communications agencies, public relations partners, creative partners, and consultants.
  • Serve as a hands-on leader in an individual contributor capacity, leveraging agency partnerships and cross-functional resources to execute communications strategies while building a scalable communications capability for the future.
  • Partner with Legal, Regulatory, Clinical Development, Medical Affairs, Commercial, and Investor Relations teams to develop, refine, and execute accurate, compliant, coordinated, and strategically effective communications strategies, messaging, and content.

About the Company

NewAmsterdam Pharma

Biopharma developing LDL-C lowering CETP therapies

NewAmsterdam Pharma develops oral therapies for cardiometabolic diseases and runs late-stage clinical programs around obicetrapib, a CETP inhibitor aimed at lowering LDL-cholesterol in high-risk cardiovascular disease patients. Its pipeline includes a fixed-dose combo of obicetrapib and ezetimibe in Phase 2 (ROSE2) and three Phase 3 trials (BROADWAY, BROOKLYN, and PREVAIL) to evaluate obicetrapib in HeFH, ASCVD, and as a cardiovascular outcomes trial. Founded in 2019 and based in Naarden, the Netherlands, the company focuses on transforming lipid management and cardiovascular risk reduction through targeted CETP inhibition.

Company size
51-200
Company stage
IPO
Headquarters
Naarden, Netherlands
Founded
2019

Recently Posted Jobs

Explore more opportunities at NewAmsterdam Pharma

See more jobs